Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Sickle Cell Disease Drug market report explains the definition, types, applications, major countries, and major players of the Sickle Cell Disease Drug market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Editas Medicine Inc
Daiichi Sankyo Co Ltd
Gilead Sciences Inc
bluebird bio Inc
Gamida Cell Ltd
Errant Gene Therapeutics LLC
Global Blood Therapeutics Inc
Angiocrine Bioscience Inc
CSL Ltd
Annexin Pharmaceuticals AB
Bio Products Laboratory Ltd
Genethon SA
ArQule Inc
Bioverativ Inc
Addmedica SAS
Acceleron Pharma Inc
Bristol-Myers Squibb Co
Calimmune Inc
CRISPR Therapeutics
By Type:
ARQ-092
BIVV-003
CAL-H
CTX-001
DRX-194
Others
By End-User:
Hospital
Clinic
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Sickle Cell Disease Drug Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Sickle Cell Disease Drug Outlook to 2028- Original Forecasts
-
2.2 Sickle Cell Disease Drug Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Sickle Cell Disease Drug Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Sickle Cell Disease Drug Market- Recent Developments
-
6.1 Sickle Cell Disease Drug Market News and Developments
-
6.2 Sickle Cell Disease Drug Market Deals Landscape
7 Sickle Cell Disease Drug Raw Materials and Cost Structure Analysis
-
7.1 Sickle Cell Disease Drug Key Raw Materials
-
7.2 Sickle Cell Disease Drug Price Trend of Key Raw Materials
-
7.3 Sickle Cell Disease Drug Key Suppliers of Raw Materials
-
7.4 Sickle Cell Disease Drug Market Concentration Rate of Raw Materials
-
7.5 Sickle Cell Disease Drug Cost Structure Analysis
-
7.5.1 Sickle Cell Disease Drug Raw Materials Analysis
-
7.5.2 Sickle Cell Disease Drug Labor Cost Analysis
-
7.5.3 Sickle Cell Disease Drug Manufacturing Expenses Analysis
8 Global Sickle Cell Disease Drug Import and Export Analysis (Top 10 Countries)
-
8.1 Global Sickle Cell Disease Drug Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Sickle Cell Disease Drug Export by Region (Top 10 Countries) (2017-2028)
9 Global Sickle Cell Disease Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Sickle Cell Disease Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global ARQ-092 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global BIVV-003 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global CAL-H Consumption and Growth Rate (2017-2022)
-
9.1.4 Global CTX-001 Consumption and Growth Rate (2017-2022)
-
9.1.5 Global DRX-194 Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Sickle Cell Disease Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Sickle Cell Disease Drug Market Analysis and Outlook till 2022
-
10.1 Global Sickle Cell Disease Drug Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Sickle Cell Disease Drug Consumption (2017-2022)
-
10.2.2 Canada Sickle Cell Disease Drug Consumption (2017-2022)
-
10.2.3 Mexico Sickle Cell Disease Drug Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Sickle Cell Disease Drug Consumption (2017-2022)
-
10.3.2 UK Sickle Cell Disease Drug Consumption (2017-2022)
-
10.3.3 Spain Sickle Cell Disease Drug Consumption (2017-2022)
-
10.3.4 Belgium Sickle Cell Disease Drug Consumption (2017-2022)
-
10.3.5 France Sickle Cell Disease Drug Consumption (2017-2022)
-
10.3.6 Italy Sickle Cell Disease Drug Consumption (2017-2022)
-
10.3.7 Denmark Sickle Cell Disease Drug Consumption (2017-2022)
-
10.3.8 Finland Sickle Cell Disease Drug Consumption (2017-2022)
-
10.3.9 Norway Sickle Cell Disease Drug Consumption (2017-2022)
-
10.3.10 Sweden Sickle Cell Disease Drug Consumption (2017-2022)
-
10.3.11 Poland Sickle Cell Disease Drug Consumption (2017-2022)
-
10.3.12 Russia Sickle Cell Disease Drug Consumption (2017-2022)
-
10.3.13 Turkey Sickle Cell Disease Drug Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Sickle Cell Disease Drug Consumption (2017-2022)
-
10.4.2 Japan Sickle Cell Disease Drug Consumption (2017-2022)
-
10.4.3 India Sickle Cell Disease Drug Consumption (2017-2022)
-
10.4.4 South Korea Sickle Cell Disease Drug Consumption (2017-2022)
-
10.4.5 Pakistan Sickle Cell Disease Drug Consumption (2017-2022)
-
10.4.6 Bangladesh Sickle Cell Disease Drug Consumption (2017-2022)
-
10.4.7 Indonesia Sickle Cell Disease Drug Consumption (2017-2022)
-
10.4.8 Thailand Sickle Cell Disease Drug Consumption (2017-2022)
-
10.4.9 Singapore Sickle Cell Disease Drug Consumption (2017-2022)
-
10.4.10 Malaysia Sickle Cell Disease Drug Consumption (2017-2022)
-
10.4.11 Philippines Sickle Cell Disease Drug Consumption (2017-2022)
-
10.4.12 Vietnam Sickle Cell Disease Drug Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Sickle Cell Disease Drug Consumption (2017-2022)
-
10.5.2 Colombia Sickle Cell Disease Drug Consumption (2017-2022)
-
10.5.3 Chile Sickle Cell Disease Drug Consumption (2017-2022)
-
10.5.4 Argentina Sickle Cell Disease Drug Consumption (2017-2022)
-
10.5.5 Venezuela Sickle Cell Disease Drug Consumption (2017-2022)
-
10.5.6 Peru Sickle Cell Disease Drug Consumption (2017-2022)
-
10.5.7 Puerto Rico Sickle Cell Disease Drug Consumption (2017-2022)
-
10.5.8 Ecuador Sickle Cell Disease Drug Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Sickle Cell Disease Drug Consumption (2017-2022)
-
10.6.2 Kuwait Sickle Cell Disease Drug Consumption (2017-2022)
-
10.6.3 Oman Sickle Cell Disease Drug Consumption (2017-2022)
-
10.6.4 Qatar Sickle Cell Disease Drug Consumption (2017-2022)
-
10.6.5 Saudi Arabia Sickle Cell Disease Drug Consumption (2017-2022)
-
10.6.6 United Arab Emirates Sickle Cell Disease Drug Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Sickle Cell Disease Drug Consumption (2017-2022)
-
10.7.2 South Africa Sickle Cell Disease Drug Consumption (2017-2022)
-
10.7.3 Egypt Sickle Cell Disease Drug Consumption (2017-2022)
-
10.7.4 Algeria Sickle Cell Disease Drug Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Sickle Cell Disease Drug Consumption (2017-2022)
-
10.8.2 New Zealand Sickle Cell Disease Drug Consumption (2017-2022)
11 Global Sickle Cell Disease Drug Competitive Analysis
-
11.1 Editas Medicine Inc
-
11.1.1 Editas Medicine Inc Company Details
-
11.1.2 Editas Medicine Inc Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Editas Medicine Inc Sickle Cell Disease Drug Main Business and Markets Served
-
11.1.4 Editas Medicine Inc Sickle Cell Disease Drug Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Daiichi Sankyo Co Ltd
-
11.2.1 Daiichi Sankyo Co Ltd Company Details
-
11.2.2 Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Main Business and Markets Served
-
11.2.4 Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Gilead Sciences Inc
-
11.3.1 Gilead Sciences Inc Company Details
-
11.3.2 Gilead Sciences Inc Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Gilead Sciences Inc Sickle Cell Disease Drug Main Business and Markets Served
-
11.3.4 Gilead Sciences Inc Sickle Cell Disease Drug Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 bluebird bio Inc
-
11.4.1 bluebird bio Inc Company Details
-
11.4.2 bluebird bio Inc Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 bluebird bio Inc Sickle Cell Disease Drug Main Business and Markets Served
-
11.4.4 bluebird bio Inc Sickle Cell Disease Drug Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Gamida Cell Ltd
-
11.5.1 Gamida Cell Ltd Company Details
-
11.5.2 Gamida Cell Ltd Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Gamida Cell Ltd Sickle Cell Disease Drug Main Business and Markets Served
-
11.5.4 Gamida Cell Ltd Sickle Cell Disease Drug Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Errant Gene Therapeutics LLC
-
11.6.1 Errant Gene Therapeutics LLC Company Details
-
11.6.2 Errant Gene Therapeutics LLC Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Errant Gene Therapeutics LLC Sickle Cell Disease Drug Main Business and Markets Served
-
11.6.4 Errant Gene Therapeutics LLC Sickle Cell Disease Drug Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Global Blood Therapeutics Inc
-
11.7.1 Global Blood Therapeutics Inc Company Details
-
11.7.2 Global Blood Therapeutics Inc Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Global Blood Therapeutics Inc Sickle Cell Disease Drug Main Business and Markets Served
-
11.7.4 Global Blood Therapeutics Inc Sickle Cell Disease Drug Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Angiocrine Bioscience Inc
-
11.8.1 Angiocrine Bioscience Inc Company Details
-
11.8.2 Angiocrine Bioscience Inc Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Angiocrine Bioscience Inc Sickle Cell Disease Drug Main Business and Markets Served
-
11.8.4 Angiocrine Bioscience Inc Sickle Cell Disease Drug Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 CSL Ltd
-
11.9.1 CSL Ltd Company Details
-
11.9.2 CSL Ltd Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 CSL Ltd Sickle Cell Disease Drug Main Business and Markets Served
-
11.9.4 CSL Ltd Sickle Cell Disease Drug Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Annexin Pharmaceuticals AB
-
11.10.1 Annexin Pharmaceuticals AB Company Details
-
11.10.2 Annexin Pharmaceuticals AB Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Annexin Pharmaceuticals AB Sickle Cell Disease Drug Main Business and Markets Served
-
11.10.4 Annexin Pharmaceuticals AB Sickle Cell Disease Drug Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Bio Products Laboratory Ltd
-
11.11.1 Bio Products Laboratory Ltd Company Details
-
11.11.2 Bio Products Laboratory Ltd Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Bio Products Laboratory Ltd Sickle Cell Disease Drug Main Business and Markets Served
-
11.11.4 Bio Products Laboratory Ltd Sickle Cell Disease Drug Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Genethon SA
-
11.12.1 Genethon SA Company Details
-
11.12.2 Genethon SA Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Genethon SA Sickle Cell Disease Drug Main Business and Markets Served
-
11.12.4 Genethon SA Sickle Cell Disease Drug Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 ArQule Inc
-
11.13.1 ArQule Inc Company Details
-
11.13.2 ArQule Inc Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 ArQule Inc Sickle Cell Disease Drug Main Business and Markets Served
-
11.13.4 ArQule Inc Sickle Cell Disease Drug Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Bioverativ Inc
-
11.14.1 Bioverativ Inc Company Details
-
11.14.2 Bioverativ Inc Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Bioverativ Inc Sickle Cell Disease Drug Main Business and Markets Served
-
11.14.4 Bioverativ Inc Sickle Cell Disease Drug Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Addmedica SAS
-
11.15.1 Addmedica SAS Company Details
-
11.15.2 Addmedica SAS Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Addmedica SAS Sickle Cell Disease Drug Main Business and Markets Served
-
11.15.4 Addmedica SAS Sickle Cell Disease Drug Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 Acceleron Pharma Inc
-
11.16.1 Acceleron Pharma Inc Company Details
-
11.16.2 Acceleron Pharma Inc Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 Acceleron Pharma Inc Sickle Cell Disease Drug Main Business and Markets Served
-
11.16.4 Acceleron Pharma Inc Sickle Cell Disease Drug Product Portfolio
-
11.16.5 Recent Research and Development Strategies
-
11.17 Bristol-Myers Squibb Co
-
11.17.1 Bristol-Myers Squibb Co Company Details
-
11.17.2 Bristol-Myers Squibb Co Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.17.3 Bristol-Myers Squibb Co Sickle Cell Disease Drug Main Business and Markets Served
-
11.17.4 Bristol-Myers Squibb Co Sickle Cell Disease Drug Product Portfolio
-
11.17.5 Recent Research and Development Strategies
-
11.18 Calimmune Inc
-
11.18.1 Calimmune Inc Company Details
-
11.18.2 Calimmune Inc Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.18.3 Calimmune Inc Sickle Cell Disease Drug Main Business and Markets Served
-
11.18.4 Calimmune Inc Sickle Cell Disease Drug Product Portfolio
-
11.18.5 Recent Research and Development Strategies
-
11.19 CRISPR Therapeutics
-
11.19.1 CRISPR Therapeutics Company Details
-
11.19.2 CRISPR Therapeutics Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.19.3 CRISPR Therapeutics Sickle Cell Disease Drug Main Business and Markets Served
-
11.19.4 CRISPR Therapeutics Sickle Cell Disease Drug Product Portfolio
-
11.19.5 Recent Research and Development Strategies
12 Global Sickle Cell Disease Drug Market Outlook by Types and Applications to 2028
-
12.1 Global Sickle Cell Disease Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global ARQ-092 Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global BIVV-003 Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global CAL-H Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global CTX-001 Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global DRX-194 Consumption Forecast and Growth Rate (2022-2028)
-
12.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Sickle Cell Disease Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Sickle Cell Disease Drug Market Analysis and Outlook to 2028
-
13.1 Global Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
13.2.2 Canada Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
13.2.3 Mexico Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
13.3.2 UK Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
13.3.3 Spain Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
13.3.4 Belgium Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
13.3.5 France Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
13.3.6 Italy Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
13.3.7 Denmark Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
13.3.8 Finland Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
13.3.9 Norway Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
13.3.10 Sweden Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
13.3.11 Poland Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
13.3.12 Russia Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
13.3.13 Turkey Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
13.4.2 Japan Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
13.4.3 India Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
13.4.4 South Korea Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
13.4.8 Thailand Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
13.4.9 Singapore Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
13.4.11 Philippines Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
13.5.2 Colombia Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
13.5.3 Chile Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
13.5.4 Argentina Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
13.5.6 Peru Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
13.6.3 Oman Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
13.6.4 Qatar Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
13.7.2 South Africa Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
13.7.3 Egypt Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
13.7.4 Algeria Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Sickle Cell Disease Drug Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Sickle Cell Disease Drug
-
Figure of Sickle Cell Disease Drug Picture
-
Table Global Sickle Cell Disease Drug Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Sickle Cell Disease Drug Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global ARQ-092 Consumption and Growth Rate (2017-2022)
-
Figure Global BIVV-003 Consumption and Growth Rate (2017-2022)
-
Figure Global CAL-H Consumption and Growth Rate (2017-2022)
-
Figure Global CTX-001 Consumption and Growth Rate (2017-2022)
-
Figure Global DRX-194 Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Sickle Cell Disease Drug Consumption by Country (2017-2022)
-
Table North America Sickle Cell Disease Drug Consumption by Country (2017-2022)
-
Figure United States Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Canada Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Mexico Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Sickle Cell Disease Drug Consumption by Country (2017-2022)
-
Figure Germany Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure UK Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Spain Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Belgium Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure France Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Italy Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Denmark Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Finland Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Norway Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Sweden Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Poland Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Russia Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Turkey Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Table APAC Sickle Cell Disease Drug Consumption by Country (2017-2022)
-
Figure China Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure India Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Thailand Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Singapore Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Philippines Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Table South America Sickle Cell Disease Drug Consumption by Country (2017-2022)
-
Figure Brazil Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Colombia Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Chile Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Argentina Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Peru Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Table GCC Sickle Cell Disease Drug Consumption by Country (2017-2022)
-
Figure Bahrain Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Oman Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Qatar Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Table Africa Sickle Cell Disease Drug Consumption by Country (2017-2022)
-
Figure Nigeria Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure South Africa Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Egypt Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Algeria Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Table Oceania Sickle Cell Disease Drug Consumption by Country (2017-2022)
-
Figure Australia Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Table Editas Medicine Inc Company Details
-
Table Editas Medicine Inc Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Editas Medicine Inc Sickle Cell Disease Drug Main Business and Markets Served
-
Table Editas Medicine Inc Sickle Cell Disease Drug Product Portfolio
-
Table Daiichi Sankyo Co Ltd Company Details
-
Table Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Main Business and Markets Served
-
Table Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Product Portfolio
-
Table Gilead Sciences Inc Company Details
-
Table Gilead Sciences Inc Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Sciences Inc Sickle Cell Disease Drug Main Business and Markets Served
-
Table Gilead Sciences Inc Sickle Cell Disease Drug Product Portfolio
-
Table bluebird bio Inc Company Details
-
Table bluebird bio Inc Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table bluebird bio Inc Sickle Cell Disease Drug Main Business and Markets Served
-
Table bluebird bio Inc Sickle Cell Disease Drug Product Portfolio
-
Table Gamida Cell Ltd Company Details
-
Table Gamida Cell Ltd Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gamida Cell Ltd Sickle Cell Disease Drug Main Business and Markets Served
-
Table Gamida Cell Ltd Sickle Cell Disease Drug Product Portfolio
-
Table Errant Gene Therapeutics LLC Company Details
-
Table Errant Gene Therapeutics LLC Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Errant Gene Therapeutics LLC Sickle Cell Disease Drug Main Business and Markets Served
-
Table Errant Gene Therapeutics LLC Sickle Cell Disease Drug Product Portfolio
-
Table Global Blood Therapeutics Inc Company Details
-
Table Global Blood Therapeutics Inc Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Global Blood Therapeutics Inc Sickle Cell Disease Drug Main Business and Markets Served
-
Table Global Blood Therapeutics Inc Sickle Cell Disease Drug Product Portfolio
-
Table Angiocrine Bioscience Inc Company Details
-
Table Angiocrine Bioscience Inc Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Angiocrine Bioscience Inc Sickle Cell Disease Drug Main Business and Markets Served
-
Table Angiocrine Bioscience Inc Sickle Cell Disease Drug Product Portfolio
-
Table CSL Ltd Company Details
-
Table CSL Ltd Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table CSL Ltd Sickle Cell Disease Drug Main Business and Markets Served
-
Table CSL Ltd Sickle Cell Disease Drug Product Portfolio
-
Table Annexin Pharmaceuticals AB Company Details
-
Table Annexin Pharmaceuticals AB Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Annexin Pharmaceuticals AB Sickle Cell Disease Drug Main Business and Markets Served
-
Table Annexin Pharmaceuticals AB Sickle Cell Disease Drug Product Portfolio
-
Table Bio Products Laboratory Ltd Company Details
-
Table Bio Products Laboratory Ltd Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bio Products Laboratory Ltd Sickle Cell Disease Drug Main Business and Markets Served
-
Table Bio Products Laboratory Ltd Sickle Cell Disease Drug Product Portfolio
-
Table Genethon SA Company Details
-
Table Genethon SA Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genethon SA Sickle Cell Disease Drug Main Business and Markets Served
-
Table Genethon SA Sickle Cell Disease Drug Product Portfolio
-
Table ArQule Inc Company Details
-
Table ArQule Inc Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table ArQule Inc Sickle Cell Disease Drug Main Business and Markets Served
-
Table ArQule Inc Sickle Cell Disease Drug Product Portfolio
-
Table Bioverativ Inc Company Details
-
Table Bioverativ Inc Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bioverativ Inc Sickle Cell Disease Drug Main Business and Markets Served
-
Table Bioverativ Inc Sickle Cell Disease Drug Product Portfolio
-
Table Addmedica SAS Company Details
-
Table Addmedica SAS Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Addmedica SAS Sickle Cell Disease Drug Main Business and Markets Served
-
Table Addmedica SAS Sickle Cell Disease Drug Product Portfolio
-
Table Acceleron Pharma Inc Company Details
-
Table Acceleron Pharma Inc Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Acceleron Pharma Inc Sickle Cell Disease Drug Main Business and Markets Served
-
Table Acceleron Pharma Inc Sickle Cell Disease Drug Product Portfolio
-
Table Bristol-Myers Squibb Co Company Details
-
Table Bristol-Myers Squibb Co Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Co Sickle Cell Disease Drug Main Business and Markets Served
-
Table Bristol-Myers Squibb Co Sickle Cell Disease Drug Product Portfolio
-
Table Calimmune Inc Company Details
-
Table Calimmune Inc Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Calimmune Inc Sickle Cell Disease Drug Main Business and Markets Served
-
Table Calimmune Inc Sickle Cell Disease Drug Product Portfolio
-
Table CRISPR Therapeutics Company Details
-
Table CRISPR Therapeutics Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table CRISPR Therapeutics Sickle Cell Disease Drug Main Business and Markets Served
-
Table CRISPR Therapeutics Sickle Cell Disease Drug Product Portfolio
-
Figure Global ARQ-092 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global BIVV-003 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CAL-H Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CTX-001 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global DRX-194 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Sickle Cell Disease Drug Consumption Forecast by Country (2022-2028)
-
Table North America Sickle Cell Disease Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Sickle Cell Disease Drug Consumption Forecast by Country (2022-2028)
-
Figure Germany Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Sickle Cell Disease Drug Consumption Forecast by Country (2022-2028)
-
Figure China Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Sickle Cell Disease Drug Consumption Forecast by Country (2022-2028)
-
Figure Brazil Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Sickle Cell Disease Drug Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Sickle Cell Disease Drug Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Sickle Cell Disease Drug Consumption Forecast by Country (2022-2028)
-
Figure Australia Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
